Press "Enter" to skip to content

Morning Break: Troubles for ‘CRISPR Babies’ Doc; FDA’s Busy Shutdown; Refugees’ Illness Risk

Note that some links may require subscriptions.

In the latest gene-edited baby news, China determined that the doctor behind the experiment violated national guidelines by acting independently and will be punished for any laws he broke. (AP News)

How extensively are doctors familiarized with LGBT health? What they learn might not be enough, according to an NPR report.

Can #ThisIsOurLane succeed without addressing racism? Brian Williams, MD, explains on KevinMD how the movement might be leaving black Americans behind.

FDA Commissioner Scott Gottlieb, MD, warned that the vaping industry will “face an existential threat” if youth use continues to rise.

And his agency just approved use of a twice-daily ocular corticosteroid for post-operative inflammation, says Alliance Contract Pharma.

Under the trade name Ontruzant, another trastuzumab (Herceptin) biosimilar will hit the U.S. market for HER2-positive breast and gastric cancers after gaining FDA approval, Samsung Bioepis announced.

In other cancer news, blockbuster drug ibrutinib (Imbruvica) failed to improve survival in patients with advanced pancreatic cancer, says AbbVie.

And macrophages, or immune cells that often lay dormant in cancer patients, can be energized to attack and eat cancer cells, according to UPenn researchers. (ScienceDaily)

Swiss researchers created a “tiny soft microswimmer robot” that can wind itself through blood vessels to deliver medication to diseased tissue. (Reuters)

Meanwhile, a team of German immunologists found a network of secret capillaries hidden deep within bones that may allow leukocytes to exit. (Nature Metabolism)

A long time coming: multiple phase II trials of stem cell therapy for age-related macular degeneration will begin this year. (STAT News)

Delaying a baby’s first bath for 12 hours could make it easier for them to latch on and breastfeed. (JOGNN)

Changing lifestyles and transitioning to a new country increases a migrant’s risk of illness, according to a novel World Health Organization report detailing the health of refugees in Europe.

Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: [email protected]